Rankings
▼
Calendar
LGVN Q3 2020 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$18M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$373,000
20.0% margin
Operating Income
-$958,000
-51.4% margin
Net Income
-$938,000
-50.3% margin
EPS (Diluted)
$-0.59
QoQ Revenue Growth
+112.9%
Cash Flow
Operating Cash Flow
-$233,000
Free Cash Flow
-$246,000
Stock-Based Comp.
$12,000
Balance Sheet
Total Assets
$10M
Total Liabilities
$7M
Stockholders' Equity
$3M
Cash & Equivalents
$1M
← FY 2020
All Quarters
Q4 2020 →